CTS CorpCTS
Price$59.81Intrinsic value$50.1016% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $554.8M+7.8% YoYTTM through 31 Mar 2026
Net Income $69.1M+24.7% YoYTTM through 31 Mar 2026
Free Cash Flow $87.6MTTM through 31 Mar 2026

Margins

Current
Gross Margin39.5%
EBITDA Margin22.2%
Operating Margin16.0%
Net Margin12.5%

Returns

12.6%ROE
7.3%ROA
13.1%ROIC

Balance Sheet Health

Debt / Equity0.11x
Current Ratio2.52x
Net Debt-$28.4Mnet cash position
Cash & Equivalents$90.9M

Quality Metrics

Altman Z-Score7.25
Piotroski F-Score8 / 9
FCF Margin15.8%
Rule of 4019.7
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $541.3M
Diluted EPS$2.34TTM
'19'20'21'22'23'24'25
FY2025: $2.19

Dividend

$0.08Per share, FY20260.14%Yield-12.9%5-yr growth

Capital Allocation

R&D Spend$25.7M
Capex Intensity2.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.